Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Rhabdomyolysis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report.

Bielen R, Verswijvel G, Van der Speeten K.

Case Rep Oncol. 2013 Jan;6(1):36-44. doi: 10.1159/000346471. Epub 2013 Jan 18.

2.

[Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].

Mátrai Z, Péley G, Kovács T, Rényi VF, Szívós E, Szabó E, Vereczkey I, Török K, Köves I.

Orv Hetil. 2006 Jan 29;147(4):147-58. Review. Hungarian.

PMID:
16515023
3.

Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ.

Ann Surg Oncol. 2009 Aug;16(8):2188-94. doi: 10.1245/s10434-009-0478-5. Epub 2009 May 2.

PMID:
19408049
4.

Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.

Cashin PH, Graf W, Nygren P, Mahteme H.

Eur J Surg Oncol. 2012 Jun;38(6):509-15. doi: 10.1016/j.ejso.2012.03.001. Epub 2012 Apr 3.

PMID:
22475555
5.

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis secondary to urachal adenocarcinoma.

Krane LS, Kader AK, Levine EA.

J Surg Oncol. 2012 Mar;105(3):258-60. doi: 10.1002/jso.22081. Epub 2011 Aug 30.

PMID:
22271499
6.

Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan.

Mizumoto A, Canbay E, Hirano M, Takao N, Matsuda T, Ichinose M, Yonemura Y.

Gastroenterol Res Pract. 2012;2012:836425. doi: 10.1155/2012/836425. Epub 2012 Jun 18.

7.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.

Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.

Ann Surg Oncol. 2009 Feb;16(2):345-51. doi: 10.1245/s10434-008-0226-2. Epub 2008 Nov 19.

PMID:
19018599
8.

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer.

Ströhlein MA, Bulian DR, Heiss MM.

Expert Rev Anticancer Ther. 2011 Oct;11(10):1505-8. doi: 10.1586/era.11.147.

PMID:
21999124
9.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination.

Wu XJ, Yuan P, Li ZY, Bu ZD, Zhang LH, Wu AW, Zong XL, Li SX, Shan F, Ji X, Ren H, Ji JF.

Tumour Biol. 2013 Feb;34(1):463-9. doi: 10.1007/s13277-012-0571-4. Epub 2012 Oct 30.

PMID:
23108893
10.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
11.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Seshadri RA, Glehen O.

World J Gastroenterol. 2016 Jan 21;22(3):1114-30. doi: 10.3748/wjg.v22.i3.1114. Review.

12.

Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?

Lambert LA, Harris A.

J Gastrointest Oncol. 2016 Feb;7(1):112-21. doi: 10.3978/j.issn.2078-6891.2015.132. Review.

13.

Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Iversen LH, Rasmussen PC, Laurberg S.

Br J Surg. 2013 Jan;100(2):285-92. doi: 10.1002/bjs.8908. Epub 2012 Nov 2.

PMID:
23124619
14.

Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.

Detroz B, Laurent S, Honoré P, Blaffart F, Limet R, Meurisse M.

Acta Chir Belg. 2004 Aug;104(4):377-83. Review.

PMID:
15469146
15.
16.

Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.

Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD.

Int J Gynecol Cancer. 2012 Jun;22(5):778-85. doi: 10.1097/IGC.0b013e31824d836c.

PMID:
22572845
17.

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.

Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z. Epub 2012 Mar 7.

PMID:
22395983
18.

The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.

Seshadri RA, Glehen O.

Indian J Surg Oncol. 2016 Jun;7(2):198-207. doi: 10.1007/s13193-016-0502-8. Epub 2016 Feb 2.

PMID:
27065710
19.

Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

Weber T, Roitman M, Link KH.

Clin Colorectal Cancer. 2012 Sep;11(3):167-76. doi: 10.1016/j.clcc.2012.01.001. Epub 2012 Mar 6. Review.

PMID:
22397952
20.

Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study.

Cashin PH, Graf W, Nygren P, Mahteme H.

Ann Oncol. 2012 Mar;23(3):647-52. doi: 10.1093/annonc/mdr301. Epub 2011 Jun 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk